Despite proven efficacy of osteoporosis medications, patients turn to dietary supplements marketed for bone health that lack ...

While rare, premenopausal idiopathic osteoporosis is marked by low BMD and fragility fractures in younger women who don't ...

Men with risk factors for osteoporosis are identified for a nurse-led program that greatly enhances the rate of screening and treatment adherence.

Strong bone-building activity was expected in this younger population, but questions remain about follow-up treatment.

For millions of women who have the bone-thinning disease osteoporosis, researchers are reporting that Fosamax, the drug most commonly used worldwide to improve bone density and prevent fractures, can ...

On Monday, the Food and Drug Administration issued a new draft guidance that requires drug manufacturers to conduct long-term nonclinical bone quality studies for osteoporosis treatments. The agency ...

NEW YORK (Reuters Health) - Few nursing home patients at high risk of bone fractures are given medications to strengthen their bones, a new study suggests. Researchers found that of more than 4,400 ...

HONG KONG SAR - EQS Newswire - 12 September 2025 - Uni-Bio Science Group ("the Group") is pleased to announce the signing of a strategic cooperation agreement with Kexing Biopharm (Stock Code: 688136.

The reduced risk for hip fracture associated with osteoporosis treatment did not differ between men vs women. Osteoporosis treatment demonstrates similar efficacy for preventing hip fracture among men ...

A common yet seriously undertreated condition, osteoporosis, is a widespread condition where the healthcare system often falls short. Researchers are ...

Zoledronic acid reduced fracture risk by 27% in men with metastatic prostate cancer receiving ADT in the STAMPEDE trial. Patients with non-metastatic disease showed no significant fracture benefit ...